SUNPHARMA - Sun Pharmaceutical Industries Limited (NSEI)

Overview

Sun Pharmaceuticals Industries Ltd, based in India, operates predominantly in the pharmaceuticals sector. It manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over the counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Backed by 43 manufacturing facilities supplies affordable medicine to more than 100 countries across the globe.

Basic Stats

The share price of Sun Pharmaceutical Industries Limited as of 5 September 2025 is ₹ 1,594.70 / share. This is a decrease of -0.25% from the prior week. The market cap (or net worth) of Sun Pharmaceutical Industries Limited as of 5 September 2025 is ₹ 3,796,587.69 MM.

The Factor Analysis chart (below right) shows a view of Sun Pharmaceutical Industries Limited from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap	3,796,587.69 MM
EV	3,704,647.09 MM
Shares Out.	2,399.33 MM
Earnings Date
EPS (TTM)	43.23
Dividend Yield	0.85 %
Ex-Dividend Date	2025-07-07

Borrow Rate
Short Shares Avail.
Short Interest
Short Float
Days to Cover

Risk Free Rate	4.22 %
Price Change (1 yr)	-13.28 %
Volatility (1 yr)	0.21
Beta	0.53
Sharpe Ratio (1 yr)	-0.85
Sortino Ratio (1 yr)	-1.33

PE Ratio	36.60
Price/Book	5.24
Price/TBV	7.00
Book/Market	0.19
EBIT/EV	0.04
EBIT(3yr avg)/EV	0.03

ROA	0.12
ROE	0.15
ROIC	0.14
CROIC	0.01
OCROIC	0.19

Implied Volatility
Put/Call OI Ratio

Growth	82.59 /100
Profitability	78.77 /100
Quality Score	72.98 /100
Value Score	55.11 /100
Momentum Score	37.15 /100
Stability (Low Vol) Score	87.02 /100
Analyst Sentiment	80.04 /100
Fund Sentiment	43.41 /100
Insider Sentiment
Officer Sentiment
Dividend Score	35.08 /100
QVM Score
Piotroski F-SCORE	9.00 /9

Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.

Price Target

The average one-year price target for Sun Pharmaceutical Industries Limited is ₹ 1,976.28. The forecasts range from a low of ₹ 1,540.25 to a high of ₹ 2,572.50. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date	Projection Date	High	Low	Median	Average
2025-09-02	2026-09-02	2,572.50	1,540.25	1,998.69	1,976.28

Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Sun Pharmaceutical Industries Limited. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:

Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date	Analyst	Latest Recommendation	Action
2021-08-02	HDFC Securities	Buy	Maintains
2021-07-31	Prabhudas Lilladhar	Buy	Maintains
2021-07-31	Motilal Oswal	Buy	Maintains
2021-07-31	ICICI Securities Limited	Hold	Maintains
2021-07-31	Prabhudas Lilladher	Buy	Maintains
2021-06-02	Geojit BNP Paribas	Buy	Maintains
2021-05-28	Prabhudas Lilladhar	Accumulate	Maintains
2021-05-28	HDFC Securities	Accumulate	Maintains
2021-05-28	ICICI Securities Limited	Hold	Maintains
2021-05-28	Motilal Oswal	Buy	Maintains
2021-01-31	ICICIdirect.com	Buy	Maintains
2021-01-31	Nirmal Bang	Buy	Maintains
2021-01-31	Nirmal Bang Institutional	Buy	Maintains
2021-01-31	Prabhudas Lilladher	Buy	Maintains
2021-01-31	ICICI Securities Limited	Buy	Maintains
2021-01-30	BOB Capital Markets Ltd.	Accumulate	Maintains
2021-01-28	Prabhudas Lilladher	Hold	Maintains
2020-12-28	Edelweiss	Neutral	Maintains
2020-12-10	Nirmal Bang Institutional	Accumulate	Maintains
2020-12-10	Nirmal Bang	Accumulate	Maintains
2020-11-05	Sharekhan	Buy	Maintains
2020-11-04	ICICIdirect.com	Buy	Maintains
2020-11-04	HDFC Securities	Accumulate	Maintains
2020-11-04	ICICI Securities Limited	Buy	Maintains
2020-11-04	BOB Capital Markets Ltd.	Sell	Maintains
2020-11-04	Nirmal Bang Institutional	Buy	Maintains
2020-11-04	Prabhudas Lilladher	Buy	Maintains
2020-09-21	Dolat Capital	Buy	Maintains
2020-08-11	SMC online	Results Update	Maintains
2020-08-07	KRChoksey	Buy	Maintains
2020-08-06	Geojit BNP Paribas	Hold	Maintains
2020-08-03	Karvy	Sell	Maintains
2020-08-03	Nirmal Bang Institutional	Buy	Maintains
2020-08-03	HDFC Securities	Accumulate	Maintains
2020-08-02	ICICI Securities Limited	Buy	Maintains
2020-08-02	ICICIdirect.com	Buy	Maintains
2020-08-02	Prabhudas Lilladher	Reduce	Maintains
2020-08-01	Motilal Oswal	Buy	Maintains
2020-08-01	BOB Capital Markets Ltd.	Sell	Maintains
2020-06-16	BOB Capital Markets Ltd.	Economy Update	Maintains
2020-06-15	Dolat Capital	Buy	Maintains
2020-06-15	BOB Capital Markets Ltd.	Sell	Maintains
2020-06-09	Geojit BNP Paribas	Buy	Maintains
2020-05-29	Karvy	Hold	Maintains
2020-05-28	ICICI Securities Limited	Buy	Maintains
2020-05-28	Nirmal Bang Institutional	Buy	Maintains
2020-05-28	Prabhudas Lilladhar	Hold	Maintains
2020-05-28	HDFC Securities	Accumulate	Maintains
2020-05-28	ICICIdirect.com	Buy	Maintains
2020-05-28	Prabhudas Lilladher	Hold	Maintains
2020-05-27	Dolat Capital	Buy	Maintains
2020-05-27	Motilal Oswal	Buy	Maintains
2020-05-27	BOB Capital Markets Ltd.	Sell	Maintains
2020-04-20	ICICI Securities Limited	Hold	Maintains
2020-02-11	SMC online	Results Update	Maintains
2020-02-11	Hem Securities	Hold	Maintains
2020-02-10	Karvy	Hold	Maintains
2020-02-07	ICICI Securities Limited	Hold	Maintains
2020-02-07	Nirmal Bang Institutional	Buy	Maintains
2020-02-07	BOB Capital Markets Ltd.	Sell	Maintains
2020-02-07	HDFC Securities	Buy	Maintains
2020-02-07	Prabhudas Lilladher	Reduce	Maintains
2020-02-06	Motilal Oswal	Buy	Maintains
2020-02-05	Prabhudas Lilladher	Reduce	Maintains
2020-02-04	Prabhudas Lilladhar	Sell	Maintains
2020-01-09	Prabhudas Lilladhar	Sell	Maintains
2019-12-21	Prabhudas Lilladhar	Sell	Maintains
2019-12-21	Prabhudas Lilladher	Reduce	Maintains
2019-12-20	Motilal Oswal	Buy	Maintains
2019-11-11	Reliance Securities	Buy	Maintains
2019-11-07	Prabhudas Lilladher	Reduce	Maintains
2019-08-16	Edelweiss	Reduce	Maintains
2019-08-14	Prabhudas Lilladher	Reduce	Maintains
2019-08-14	Reliance Securities	Buy	Maintains
2019-08-14	HDFC Securities	Buy	Maintains
2019-08-14	Nirmal Bang	Buy	Maintains
2019-08-14	Karvy Stock Broking	Hold	Maintains
2019-08-13	Sharekhan	Hold	Maintains
2019-05-30	HDFC Securities	Buy	Maintains
2019-05-30	Reliance Securities	Buy	Maintains
2019-05-29	ICICIdirect.com	Hold	Maintains
2019-05-29	Nirmal Bang	Buy	Maintains
2019-05-29	Karvy Stock Broking	Hold	Maintains
2019-05-29	Motilal Oswal	Buy	Maintains
2019-04-04	IIFL	Reduce	Maintains
2019-03-07	Nirmal Bang	Buy	Maintains
2019-02-15	Reliance Securities	Buy	Maintains
2019-02-14	HDFC Securities	Buy	Maintains
2019-02-13	Motilal Oswal	Buy	Maintains
2019-02-13	Karvy Stock Broking	Hold	Maintains
2019-02-13	ICICIdirect.com	Hold	Maintains
2019-01-23	Motilal Oswal	Buy	Maintains
2019-01-23	Reliance Securities	Buy	Maintains
2018-12-05	ICICIdirect.com	Hold	Maintains
2018-12-04	Edelweiss	Book Profit	Maintains
2018-12-04	Sharekhan	Hold	Maintains
2018-11-15	HDFC Securities	Buy	Maintains
2018-11-13	Prabhudas Lilladher	Reduce	Maintains
2018-11-05	HDFC Securities	Buy	Maintains
2018-10-30	Geojit Financial Services	Buy	Maintains

SUNPHARMA - Sun Pharmaceutical Industries Limited (NSEI) - Share Price and News

Overview

Basic Stats

Price Target

Stock Upgrades/Downgrades

Other Listings